CRISPR/Cas9-Mediated SHP-1-Knockout T Cells Combined with Simvastatin Exhibit Enhanced Anti-Tumor Activity in Hepatocellular Carcinoma
Published: 4 December 2024| Version 1 | DOI: 10.17632/gnkgbjpc2x.1
Contributor:
华子 刘Description
Sample at figure 6 and supplementary figure 10
Files
Institutions
Central South University
Categories
RNA Sequencing